General Biotechnology

DrugPatentWatch provides competitive intelligence on small-molecule drugs and the 90,000 global patents covering them

Click the patents below for more details, or visit DrugPatentWatch.com for more options.

ABILIFY MAINTENA KIT (aripiprazole)
Otsuka Pharm Co Ltd
Patent number: 5,006,528
Expiration Date: Apr 20, 2015


ABILIFY (aripiprazole)
Otsuka
Patent number: 5,006,528
Expiration Date: Apr 20, 2015


CAVERJECT (alprostadil)
Pharmacia And Upjohn
Patent number: 5,741,523
Expiration Date: Apr 21, 2015


EXUBERA (insulin recombinant human)
Pfizer
Patent number: 5,740,794
Expiration Date: Apr 21, 2015


OXYTROL (oxybutynin)
Actavis Labs Ut Inc
Patent number: 5,601,839
Expiration Date: Apr 26, 2015


OXYTROL FOR WOMEN (oxybutynin)
Bayer Healthcare Llc
Patent number: 5,601,839
Expiration Date: Apr 26, 2015


OXYTROL (oxybutynin)
Actavis Labs Ut Inc
Patent number: 5,834,010
Expiration Date: Apr 26, 2015


OXYTROL FOR WOMEN (oxybutynin)
Bayer Healthcare Llc
Patent number: 5,834,010
Expiration Date: Apr 26, 2015


For more information try a free trial

DrugPatentWatch provides competitive intelligence on small-molecule drugs and the 90,000 global patents covering them

Click the patents below for more details, or visit DrugPatentWatch.com for more options.

ABILIFY MAINTENA KIT (aripiprazole)
Otsuka Pharm Co Ltd
Patent number: 5,006,528
Expiration Date: Apr 20, 2015


ABILIFY (aripiprazole)
Otsuka
Patent number: 5,006,528
Expiration Date: Apr 20, 2015


CAVERJECT (alprostadil)
Pharmacia And Upjohn
Patent number: 5,741,523
Expiration Date: Apr 21, 2015


EXUBERA (insulin recombinant human)
Pfizer
Patent number: 5,740,794
Expiration Date: Apr 21, 2015


OXYTROL FOR WOMEN (oxybutynin)
Bayer Healthcare Llc
Patent number: 5,834,010
Expiration Date: Apr 26, 2015


OXYTROL (oxybutynin)
Actavis Labs Ut Inc
Patent number: 5,601,839
Expiration Date: Apr 26, 2015


OXYTROL FOR WOMEN (oxybutynin)
Bayer Healthcare Llc
Patent number: 5,601,839
Expiration Date: Apr 26, 2015


OXYTROL (oxybutynin)
Actavis Labs Ut Inc
Patent number: 5,834,010
Expiration Date: Apr 26, 2015


For more information try a free trial

TechTransferWatch is a search engine and alert service for licenseable technologies from academic labs, foundations, and government.

Click the patents below for more details, or visit TechTransferWatch.com for more options.

Passive electric field focus system for in vivo and in vitro applications
Jose I. Rey, Richard Gilbert, Mark J. Jaroszeski, Richard Heller
University of South Florida
Patent number: 9,014,800
Issue Date: April 21, 2015



Cyril Falentin, Michel Bregeon, Marie Odile Lucas, Michel Renard
Institut National de la Recherche Agronomique
Patent number: 9,012,718
Issue Date: April 21, 2015


Recovery method of highly pure lactic acid and alkyl lactate
Dong Won Hwang, Jong-San Chang, Young Kyu Hwang, U-Hwang Lee, HyoJin Gwak
Korea Research Institute of Chemical Technology
Patent number: 9,012,685
Issue Date: April 21, 2015


Methods for assaying α-L-iduronidase enzymatic activity
Michael H. Gelb, Sophie Blanchard
University of Washington
Patent number: 9,012,663
Issue Date: April 21, 2015


Antimicrobial compounds and uses thereof
Agency for Science, Technology and Research
Patent number: 9,012,505
Issue Date: April 21, 2015


Pharmaceutical anti-angiogenic composition including a MicroRNA-382 inhibitor
You Mie Lee
Kyungpook National University
Patent number: 9,012,426
Issue Date: April 21, 2015


Methods for the treatment of Leber congenital amaurosis
Jean-Michel Rozet, Antoine Kichler, Isabelle Perrault, Josseline Kaplan, Xavier Gerard, Daniel Scherman, M. Arnold Munnich, Jean-Michel Rozet, Antoine Kichler, Isabelle Perrault, Josseline Kaplan, Xavier Gerard, Daniel Scherman, M. Arnold Munnich
Paris Descartes University
Patent number: 9,012,425
Issue Date: April 21, 2015


Methods and compositions related to eosinophil regulation
Lori A. Wagner, Katrin Szardenings, Gerald J. Gleich, Tarek Aboul-Fadl Mohamed
University of Utah
Patent number: 9,012,419
Issue Date: April 21, 2015


Rapid screening method of translational fusion partners for producing recombinant proteins and translational fusion partners screened therefrom
Korea Research Institute of Bioscience and Biotechnology
Patent number: 9,012,367
Issue Date: April 21, 2015


Chimeric vectors
Dawn E. Bowles, Chengwen Li, Joseph E. Rabinowitz, Josh Grieger, Mavis Agbandje-McKenna, Richard Jude Samulski, Dawn E. Bowles, Chengwen Li, Joseph E. Rabinowitz, Josh Grieger, Mavis Agbandje-McKenna, Richard Jude Samulski
University of North Carolina, Chapel Hill
Patent number: 9,012,224
Issue Date: April 21, 2015


Methods for enhancing genome stability and telomere elongation in embryonic stem cells
Department of Health and Human Services
Patent number: 9,012,223
Issue Date: April 21, 2015


RNA preparations comprising purified modified RNA for reprogramming cells
Katalin Kariko, Drew Weissman, Gary Dahl, Anthony Person, Judith Meis, Jerome Jendrisak
University of Pennsylvania
Patent number: 9,012,219
Issue Date: April 21, 2015


Methods for identifying leukemia stem cells and distinguishing them from normal hematopietic stem cells in patients with acute myeloid leukemia: uses in diagnosis, treatment, and research
Jonathan Michael Gerber, Richard John Jones
Johns Hopkins University
Patent number: 9,012,215
Issue Date: April 21, 2015


Microfluidic device, system, and method for controlled encapsulation of particles or particle clusters
Florence Rivera, Jean Berthier, Sophie Le Vot
Commissariat a l’Energies Atomique et aux Energies Alternatives
Patent number: 9,012,203
Issue Date: April 21, 2015


Micro-bubble plate for patterning biological and non-biological materials
University of California
Patent number: 9,012,193
Issue Date: April 21, 2015


Modified alcohol dehydrogenases for the production of fuels and chemicals
Sabine Bastian, Frances Arnold, Peter Meinhold
California Institute of Technology
Patent number: 9,012,189
Issue Date: April 21, 2015


Use of template switching for DNA synthesis
Alan M. Lambowitz, Sabine Mohr, Travis B. White, Scott Kuersten
University of Texas System
Patent number: 9,012,183
Issue Date: April 21, 2015


Method for mass-producing antifreeze protein derived from polar yeast
Hakjun Kim, Sungho Kang, Junhyuck Lee, Sunggu Lee, Sejong Han, Jongchan Park, Kyoungsun Park
Korea Ocean Research and Development Institute
Patent number: 9,012,179
Issue Date: April 21, 2015


Methods and compositions for improving sugar transport, mixed sugar fermentation, and production of biofuels
, , , , ,
University of Illinois
Patent number: 9,012,177
Issue Date: April 21, 2015


Mutant AOX1 promoters
Franz Hartner, Anton Glieder
Graz University of Technology
Patent number: 9,012,175
Issue Date: April 21, 2015


Split peroxidases and methods of use
Massachusetts Institute of Technology
Patent number: 9,012,170
Issue Date: April 21, 2015


Anti-bacterial peptides and methods of treating diseases using same
Hanna Engelberg-Kulka, Ilana Kolodkin-Gal
Hebrew University of Jerusalem
Patent number: 9,012,152
Issue Date: April 21, 2015


Method of enzymatic gene chip detection kit
Fooyin University Hospital
Patent number: 9,012,147
Issue Date: April 21, 2015


Protein tyrosine phosphatase mutations in cancers
Zhenghe Wang, Victor Velculescu, Kenneth W. Kinzler, Bert Vogelstein
Johns Hopkins University
Patent number: 9,012,145
Issue Date: April 21, 2015


Polymorphisms in genes affecting ace-related disorders and uses thereof
Wolfgang Sadee, Andrew D. Johnson, Danxin Wang, Audrey C. Papp
Ohio State University
Patent number: 9,012,143
Issue Date: April 21, 2015


Sequence-specific detection of nucleotide sequences
Mark Danielsen, Eugene A. Davidson, Kenneth L. Dretchen, Traci K. Pals
Georgetown University
Patent number: 9,012,142
Issue Date: April 21, 2015


Method for enzymatic treatment, device and kit used the same
Industrial Technology Research Institute (ITRI)
Patent number: 9,011,917
Issue Date: April 21, 2015


Use of specific peptides in the preparation of a medicament for the treatment of monoclonal gammopathy of undetermined significance (MGUS) or of smoldering multiple myeloma (SMM)
Michael Hundemer, Olaf Christensen
Heidelberg University
Patent number: 9,011,867
Issue Date: April 21, 2015


RNA interference that blocks expression of pro-apoptotic proteins potentiates immunity induced by DNA and transfected dendritic cell vaccines
Tzyy-Choou Wu, Chien-Fu Hung
Johns Hopkins University
Patent number: 9,011,866
Issue Date: April 21, 2015


Human cystathionine β-synthase variants and methods of production thereof
University of Colorado
Patent number: 9,011,844
Issue Date: April 21, 2015


Screening tool for antiviral agents
Karoly Toth, William S. M. Wold
Saint Louis University
Patent number: 9,011,820
Issue Date: April 21, 2015


Manufacturing three-dimensional scaffolds using electrospinning at low temperatures
Meng Fatt Leong, Tze Chiun Lim, Kerm Sin Chian
Nanyang Technological University
Patent number: 9,011,754
Issue Date: April 21, 2015


Journal of Commercial Biotechnology This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology

Current and future prospects for the global biotechnology industry

Go to paper

ABSTRACT: The number of biotechnology compounds has been increasing steadily over the past 20 years, reflecting the key contribution that biotechnology is now making to healthcare. Recombinant DNA technology has been used to develop a number of therapeutic proteins, including antibodies, cytokines, hormones and vaccines for use in tackling and diagnosing a range of disorders...

The Journal of Commercial Biotechnology is a unique forum for all those involved in biotechnology commercialization to present, share, and explore new ideas, latest thinking and best practices, making it an indispensable guide for those developing projects and careers within this fast moving field.

Each issue publishes peer-reviewed, authoritative, cutting-edge articles written by the leading practitioners and researchers in the field, addressing topics such as:

  • Management
  • Policy
  • Finance
  • Law
  • Regulation
  • Bioethics

For more information, see the Journal of Commercial Biotechnology website

This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? Respond in the comments section below.

Susan Kling Finston

Nascent life sciences start-ups in the BRICS and other emerging markets face continuing fundraising hurdles, as discussed here and more recently here. So while there have been increasing calls for India’s small-scale entrepreneurs to move from ‘jugaad’ to more Israeli-style start-ups, access to capital has not kept pace with India’s appetite for innovation. Understanding just how limited India’s public funding is for biotech start-ups may help to explain the importance of this issue.

The Indian Department of Biotechnology (DBT) provides the lion’s share of domestic funding for R&D-Intensive Micro-Small & Medium Enterprises (MSMEs). Not taking into account limitations in actual disbursement of budgeted funds, the DBT’s stated funding for the SBIRI, BIPP and other R&D programs amounted to less than $15 million annually in recent years: “For 2013-14, the allocations are merely 90 crores,” (p. 44). Of this total, the lion’s share historically has aided established pharmaceutical / biotech companies.  

Accordingly, the Modi Government should look beyond public sectors funding schemes for biotech startups, where tax incentives to energize Angel Investors may play an important role in dramatically increasing funding for innovative start-ups. Both Israel and the US provide R&D Investment tax credits that serve as effective incentives for funding ‘high risk-high reward’ ventures, with immediate benefits to Angels who traditionally provide seed funding to start-ups at earlier stages than VCs. 

Issues relating to broader tax reforms and the need for tax incentives for high net worth individuals (HNWI) to create a broad class of Angel Investors surfaced over the course of the April 15th CSIS program: Deepening the U.S.-India Commercial Partnership: The First Year of the Modi Government, co-organized by the Wadhwani Foundation and the Ananta Aspen Centre. India’s private sector represents a huge, untapped source of capital to support job creation through funding of R&D-intensive MSMEs.  With a total of 14,800 multimillionaires and 2,700 multimillionaires in Mumbai alone, India ranks in 8th place globally in terms of the number of multimillionaires and is home to the 4th largest number of billionaires around the world.

India ranks in 8th place globally in terms of the number of multimillionaires and is home to the 4th largest number of billionaires around the world

With the right tax incentives, these High Net Worth Individuals (HNWIs) may take flight as a new Angel Investor class, easily surpassing limited public funds available to India’s R&D intensive MSMEs. Giving Angel Investors their wings could help an unprecedented number of MSME innovators, leading to a virtuous circle of job creation and development of new pharmaceutical and biotechnology products that are ‘made in India.’

More information on investment tax credits and how India may benefit through selective adaptation of Israeli and US policies for R&D intensive MSMEs may be found in the Wadhwani Foundation’s Innovation Blueprint Study, available for download here.

 

About the author:
President of Finston Consulting LLC since 2005, Susan works with innovative biotechnology and other clients ranging from start-up to Fortune-100, providing support for legal, transactional, policy and “doing business” issues. Susan has extensive background and special expertise relating to intellectual property and knowledge-economy issues in advanced developing countries including India and South Asia, Latin America and the Middle East North Africa (MENA) region. She also works with governments, and NGOs on capacity building and related educational programs through BayhDole25. Together with biotechnology pioneer Ananda Chakrabarty, she also is co-founder of Amrita Therapeutics Ltd., an emerging biopharmaceutical company based in India with cancer peptide drugs entering in vivo research. Previous experience includes 11 years in the U.S Foreign Service with overseas tours in London, Tel Aviv, and Manila and at the Department of State in Washington DC. For more information on latest presentations and publications please visit finstonconsulting.com.

DrugPatentWatch provides competitive intelligence on small-molecule drugs and the 90,000 global patents covering them

Click the patents below for more details, or visit DrugPatentWatch.com for more options.

ALOXI (palonosetron hydrochloride)
Helsinn Hlthcare
Patent number: 5,202,333
Expiration Date: Apr 13, 2015


AKYNZEO (netupitant; palonosetron hydrochloride)
Helsinn Hlthcare
Patent number: 5,202,333
Expiration Date: Apr 13, 2015


GATTEX KIT (teduglutide recombinant)
Nps Pharms Inc
Patent number: 5,789,379
Expiration Date: Apr 14, 2015


JUXTAPID (lomitapide mesylate)
Aegerion
Patent number: 5,739,135
Expiration Date: Apr 14, 2015


MYLOTARG (gemtuzumab ozogamicin)
Wyeth Pharms Inc
Patent number: 5,739,116
Expiration Date: Apr 14, 2015


CLEVIPREX (clevidipine)
Medicines Co
Patent number: 5,739,152
Expiration Date: Apr 14, 2015


EMEND (aprepitant)
Merck
Patent number: 5,719,147
Expiration Date: Apr 17, 2015


For more information try a free trial

DrugPatentWatch provides competitive intelligence on small-molecule drugs and the 90,000 global patents covering them

Click the patents below for more details, or visit DrugPatentWatch.com for more options.

AKYNZEO (netupitant; palonosetron hydrochloride)
Helsinn Hlthcare
Patent number: 5,202,333
Expiration Date: Apr 13, 2015


ALOXI (palonosetron hydrochloride)
Helsinn Hlthcare
Patent number: 5,202,333
Expiration Date: Apr 13, 2015


CLEVIPREX (clevidipine)
Medicines Co
Patent number: 5,739,152
Expiration Date: Apr 14, 2015


GATTEX KIT (teduglutide recombinant)
Nps Pharms Inc
Patent number: 5,789,379
Expiration Date: Apr 14, 2015


JUXTAPID (lomitapide mesylate)
Aegerion
Patent number: 5,739,135
Expiration Date: Apr 14, 2015


MYLOTARG (gemtuzumab ozogamicin)
Wyeth Pharms Inc
Patent number: 5,739,116
Expiration Date: Apr 14, 2015


EMEND (aprepitant)
Merck
Patent number: 5,719,147
Expiration Date: Apr 17, 2015


For more information try a free trial

Drug Patent Expirations for April 2015

Tradename Applicant Generic Name Patent Number Patent Expiration
FAMVIR Novartis famciclovir 6,124,304*PED Apr 4, 2015
FAMVIR Novartis famciclovir 5,866,581*PED Apr 4, 2015
PROVIGIL Cephalon modafinil RE37516*PED Apr 6, 2015
NUVIGIL Cephalon armodafinil RE37516*PED Apr 6, 2015
ADVAIR HFA Glaxo Grp Ltd fluticasone propionate; salmeterol xinafoate 5,674,472*PED Apr 7, 2015
HYCAMTIN Glaxosmithkline topotecan hydrochloride 5,674,872*PED Apr 7, 2015
FLOVENT HFA Glaxo Grp Ltd fluticasone propionate 5,674,472*PED Apr 7, 2015
AKYNZEO Helsinn Hlthcare netupitant; palonosetron hydrochloride 5,202,333 Apr 13, 2015
ALOXI Helsinn Hlthcare palonosetron hydrochloride 5,202,333 Apr 13, 2015
JUXTAPID Aegerion lomitapide mesylate 5,739,135 Apr 14, 2015
MYLOTARG Wyeth Pharms Inc gemtuzumab ozogamicin 5,739,116 Apr 14, 2015
GATTEX KIT Nps Pharms Inc teduglutide recombinant 5,789,379 Apr 14, 2015
CLEVIPREX Medicines Co clevidipine 5,739,152 Apr 14, 2015
EMEND Merck aprepitant 5,719,147 Apr 17, 2015
ABILIFY MAINTENA KIT Otsuka Pharm Co Ltd aripiprazole 5,006,528 Apr 20, 2015
ABILIFY Otsuka aripiprazole 5,006,528*PED Apr 20, 2015
CAVERJECT Pharmacia And Upjohn alprostadil 5,741,523 Apr 21, 2015
EXUBERA Pfizer insulin recombinant human 5,740,794 Apr 21, 2015
OXYTROL Watson Labs (utah) oxybutynin 5,601,839 Apr 26, 2015
OXYTROL FOR WOMEN Bayer Healthcare Llc oxybutynin 5,601,839 Apr 26, 2015
OXYTROL Watson Labs (utah) oxybutynin 5,834,010 Apr 26, 2015
OXYTROL FOR WOMEN Bayer Healthcare Llc oxybutynin 5,834,010 Apr 26, 2015
LAMISIL Novartis terbinafine 5,681,849*PED Apr 28, 2015
MAVIK Abbvie trandolapril 5,744,496 Apr 28, 2015
LAMISIL AT Novartis terbinafine 5,681,849*PED Apr 28, 2015
LAMISIL AT Novartis terbinafine hydrochloride 5,681,849*PED Apr 28, 2015
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.
Contact Us with any questions.

Drug Patent Expirations for April 2015

Tradename Applicant Generic Name Patent Number Patent Expiration
FAMVIR Novartis famciclovir 5,866,581*PED Apr 4, 2015
FAMVIR Novartis famciclovir 6,124,304*PED Apr 4, 2015
PROVIGIL Cephalon modafinil RE37516*PED Apr 6, 2015
NUVIGIL Cephalon armodafinil RE37516*PED Apr 6, 2015
ADVAIR HFA Glaxo Grp Ltd fluticasone propionate; salmeterol xinafoate 5,674,472*PED Apr 7, 2015
HYCAMTIN Glaxosmithkline topotecan hydrochloride 5,674,872*PED Apr 7, 2015
FLOVENT HFA Glaxo Grp Ltd fluticasone propionate 5,674,472*PED Apr 7, 2015
AKYNZEO Helsinn Hlthcare netupitant; palonosetron hydrochloride 5,202,333 Apr 13, 2015
ALOXI Helsinn Hlthcare palonosetron hydrochloride 5,202,333 Apr 13, 2015
MYLOTARG Wyeth Pharms Inc gemtuzumab ozogamicin 5,739,116 Apr 14, 2015
GATTEX KIT Nps Pharms Inc teduglutide recombinant 5,789,379 Apr 14, 2015
CLEVIPREX Medicines Co clevidipine 5,739,152 Apr 14, 2015
JUXTAPID Aegerion lomitapide mesylate 5,739,135 Apr 14, 2015
EMEND Merck aprepitant 5,719,147 Apr 17, 2015
ABILIFY MAINTENA KIT Otsuka Pharm Co Ltd aripiprazole 5,006,528 Apr 20, 2015
ABILIFY Otsuka aripiprazole 5,006,528*PED Apr 20, 2015
CAVERJECT Pharmacia And Upjohn alprostadil 5,741,523 Apr 21, 2015
EXUBERA Pfizer insulin recombinant human 5,740,794 Apr 21, 2015
OXYTROL Watson Labs (utah) oxybutynin 5,601,839 Apr 26, 2015
OXYTROL FOR WOMEN Bayer Healthcare Llc oxybutynin 5,601,839 Apr 26, 2015
OXYTROL Watson Labs (utah) oxybutynin 5,834,010 Apr 26, 2015
OXYTROL FOR WOMEN Bayer Healthcare Llc oxybutynin 5,834,010 Apr 26, 2015
MAVIK Abbvie trandolapril 5,744,496 Apr 28, 2015
LAMISIL AT Novartis terbinafine 5,681,849*PED Apr 28, 2015
LAMISIL AT Novartis terbinafine hydrochloride 5,681,849*PED Apr 28, 2015
LAMISIL Novartis terbinafine 5,681,849*PED Apr 28, 2015
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.
Contact Us with any questions.

TechTransferWatch is a search engine and alert service for licenseable technologies from academic labs, foundations, and government.

Click the patents below for more details, or visit TechTransferWatch.com for more options.

F-box protein targeted plant oil production
John B. Ohlrogge, Sari A. Ruuska, Yonghua Li
Michigan State University
Patent number: 9,006,518
Issue Date: April 14, 2015


Method for isolating nucleic acids
Pei-Shin Jiang, Kun-Chan Wu, Yu-Ting Su, Chia-Yun Lin, Siou-Cing Su, Yuh-Jiuan Lin
Industrial Technology Research Institute (ITRI)
Patent number: 9,006,419
Issue Date: April 14, 2015


PCP2 mini-promoters
University of British Columbia
Patent number: 9,006,413
Issue Date: April 14, 2015


Expression vector for pseudonocardia autotrophica
Yoshikazu Fujii, Tadashi Fujii, Akira Arisawa, Tomohiro Tamura
Japan National Institute of Advanced Industrial Science and Technology
Patent number: 9,006,412
Issue Date: April 14, 2015


Endometriosis cell targeting peptide and uses thereof
Michiko Fukuda, Daisuke Aoki, Noriko Nozawa, Michiko Fukuda, Daisuke Aoki, Noriko Nozawa
Sanford-Burnham Medical Research Institute
Patent number: 9,006,404
Issue Date: April 14, 2015


Repeat protein from collection of repeat proteins comprising repeat modules
Michael Tobias Stumpp, Patrik Forrer, Hans Kaspar Binz, Andreas Pluckthun
University of Zurich
Patent number: 9,006,389
Issue Date: April 14, 2015


Compositions and methods for pest control
Ido Bachelet, Ram Sasisekharan, Mark Bulmer, Rebeca B. Rosengaus, Ido Bachelet, Ram Sasisekharan, Mark Bulmer, Rebeca B. Rosengaus
Northeastern University
Patent number: 9,006,212
Issue Date: April 14, 2015


Antisense oligonucleotides against neutral sphingomyelinase and neutral sphingomyelinase inhibitor GW4869 for degenerative neurological disorders
Kalipada Pahan
Rush University Medical Center
Patent number: 9,006,205
Issue Date: April 14, 2015


Method of reducing inflammatory infiltration in subjects with inflammatory lung disease
Department of Health and Human Services
Patent number: 9,006,203
Issue Date: April 14, 2015


Selective reduction of allelic variants
C. Frank Bennett, Michael Hayden, Susan M. Freier, Sarah Greenlee, Jeffrey Carroll, Simon Warby, Eric E. Swayze
University of British Columbia
Patent number: 9,006,198
Issue Date: April 14, 2015


Compositions and methods for diminishing viral infection and inflammation associated with viral infection
Peter D. Katsikis, Alina C. Boesteanu, Sefik S. Alkan
Drexel University
Patent number: 9,006,194
Issue Date: April 14, 2015


Selective targeting agents for mitochondria
University of Pittsburgh
Patent number: 9,006,186
Issue Date: April 14, 2015


Methods of protecting against apoptosis using lipopeptides
Cleveland Clinic
Patent number: 9,006,183
Issue Date: April 14, 2015


Immobilizing fusion protein for effective and oriented immobilization of antibody on surfaces
Hyung Joon Cha, Chang Sup Kim
Pohang University of Science and Technology
Patent number: 9,005,992
Issue Date: April 14, 2015


Selection method of induced pluripotent stem cells
Shinya Yamanaka, Takayuki Tanaka
Kyoto University
Patent number: 9,005,976
Issue Date: April 14, 2015


Method for selecting clone of induced pluripotent stem cells
Hideyuki Okano, Yohei Okada, Shinya Yamanaka, Kyoko Miura
Kyoto University
Patent number: 9,005,975
Issue Date: April 14, 2015


Induction of pluripotent cells
Tongxiang Lin, Sheng Ding
Scripps Research Institute
Patent number: 9,005,968
Issue Date: April 14, 2015


Myc variants improve induced pluripotent stem cell generation efficiency
Shinya Yamanaka, Masato Nakagawa
Kyoto University
Patent number: 9,005,967
Issue Date: April 14, 2015


Generation of pluripotent cells from fibroblasts
William E. Lowry, Kathrin Plath
University of California
Patent number: 9,005,966
Issue Date: April 14, 2015


Regionalised endoderm cells and uses thereof
Gillian Mary Morrison, Joshua Mark Brickman, Ifigenia Oikonomopoulou
University of Edinburgh
Patent number: 9,005,962
Issue Date: April 14, 2015


Buoyant triacylglycerol-filled green algae and methods therefor
Washington University
Patent number: 9,005,955
Issue Date: April 14, 2015


Methods for isolating bacteria
Jean-Paul Leonetti, Stéphanie Texier
Centre National de la Recherche Scientifique
Patent number: 9,005,954
Issue Date: April 14, 2015


Use of
Wim Soetaert, Sofie De Maeseneire, Karen Saerens, Sophie Roelants, Inge Van Bogaert
Ghent University
Patent number: 9,005,923
Issue Date: April 14, 2015


Sensor chip for screening topoisomerase inhibitor and screening method thereof
Chun-Mao Lin, Hsiang-Ping Tsai, Chwen-Ming Shih, Jau-Lang Hwang, Chi-Ming Lee
Taipei Medical University
Patent number: 9,005,922
Issue Date: April 14, 2015


Hybridoma cell line for producing antibody for type II collagen
Chih-Hsin Hung, Chi-Yen Shen, Shyh-Ming Kuo, I-Fen Chen, Shih-Han Wang
I-Shou University
Patent number: 9,005,912
Issue Date: April 14, 2015


Risk markers for cardiovascular disease
Cleveland Clinic
Patent number: 9,005,904
Issue Date: April 14, 2015


Method of deriving progenitor cell line
Agency for Science, Technology and Research
Patent number: 9,005,897
Issue Date: April 14, 2015


Alloy nanoparticles for metal-enhanced luminescence
Venkat R. Bhethanabotla, Sanchari Chowdhury
University of South Florida
Patent number: 9,005,890
Issue Date: April 14, 2015


Membrane proximal region of HIV gp41 anchored to the lipid layer of a virus-like particle vaccine
Ira Berkower
Department of Health and Human Services
Patent number: 9,005,631
Issue Date: April 14, 2015


Biotherapy for pain
James Oliver Dolly, Jiafu Wang, Jianghui Meng
Dublin City University
Patent number: 9,005,628
Issue Date: April 14, 2015


Detection of nucleic acid lesions and adducts using nanopores
Cynthia J. Burrows, Henry S. White, Ryuji Kawano, Aaron M. Fleming, Na An
University of Utah
Patent number: 9,005,425
Issue Date: April 14, 2015